This is a demo for an Agent-based epidemiology code built using the AMReX framework.

For more information about AMReX: website: https://amrex-codes.github.io/ documentation: https://amrex-codes.github.io/amrex/docs_html/ source code: https://github.com/AMReX-Codes/amrex

Building the code

This demo uses CMake version 3.14 or higher. To build it: mkdir build cd build cmake .. make -j8

To build with GPU support, use the -DAMReX_GPU_BACKEND=CUDA CMake option.

To write output as (compressed) HDF5, use the -DAMReX_HDF5=TRUE CMake option. Parallel HDF5 installation is required. On perlmutter, a conda environment is available at:

conda activate /global/common/software/m3623/exaepi

Compression level can be altered in src/IO.cpp file. The environment variable HDF5_CHUNK_SIZE controls the chunk size if compression is used. A value of around 100,000 is recommended to start.

For convenience, a script for setting up the module environment without HDF5 for Perlmutter is provided in etc/perlmutter_environment.sh. To use it, do:

source etc/perlmutter_environment.sh

Running the code

Navigate to build/bin and run the executable using one of the "inputs" files in "examples".

For example: cd build/bin ./agent ../../examples/inputs

Looking at the output

Running the code succesfully will create a number of "plt?????" files. You can visualize these using the script at etc/plot.py. This will require the "yt" package to be installed:

https://yt-project.org/

Copyright Notice

ExaEpi Copyright (c) 2022, The Regents of the University of California, through Lawrence Berkeley National Laboratory (subject to receipt of any required approvals from the U.S. Dept. of Energy). All rights reserved.

If you have questions about your rights to use or distribute this software, please contact Berkeley Lab's Intellectual Property Office at IPO@lbl.gov.

NOTICE. This Software was developed under funding from the U.S. Department of Energy and the U.S. Government consequently retains certain rights. As such, the U.S. Government has been granted for itself and others acting on its behalf a paid-up, nonexclusive, irrevocable, worldwide license in the Software to reproduce, distribute copies to the public, prepare derivative works, and perform publicly and display publicly, and to permit others to do so.